Trial Information

Summary: Spectradigital - New Investigational Test to Measure Resistance to Anti-HIV Drugs

This study investigates the efficacy of an in vitro diagnostic device, HIV SpectraPoint, in HIV positive volunteers with prior resistance to antiretroviral medications.

Patient Inclusion Criteria

• HIV-1 positive adults at least 18 years of age,
• HIV-1 RNA greater than 500 copies/mL
• Documented genotypic evidence of resistance to any currently available antiretroviral drug

Patient Exclusion Criteria

• Acute or chronic Hepatitis B

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:32:50 AM